Prognostic value of B-type natriuretic peptide and its amino-terminal proBNP fragment for cardiovascular events with stratification by renal function

Journal of Cardiology

Volumn 61, Issue 6, 2013, Pages 410-416

  Horii, Manabu ^a   Matsumoto, Takaki ^a   Uemura, Shiro ^a   Sugawara, Yu ^a   Takitsume, Akihiro ^a   Ueda, Tomoya ^a   Nakagawa, Hitoshi ^a   Nishida, Taku ^a   Soeda, Tsunenari ^a   Okayama, Satoshi ^a   Somekawa, Satoshi ^a   Ishigami, Kenichi ^a   Takeda, Yukiji ^a   Kawata, Hiroyuki ^a   Kawakami, Rika ^a   Saito, Yoshihiko ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

BNP; Chronic kidney disease; Heart failure; NT proBNP

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HEART FAILURE; HEART INFARCTION; HEMODIALYSIS; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; COHORT STUDIES; ENDPOINT DETERMINATION; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HUMANS; KIDNEY; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; ROC CURVE; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84879004632     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2013.01.015     Document Type: Article

References (23)

1. Bruins S., Fokkema M.R., Römer J.W., Dejongste M.J., van der Dijs F.P., van den Ouweland J.M. High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure. Clin Chem 2004, 50:2052-2058.
2. Maeda K., Tsutamoto T., Wada A., Hisanaga T., Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998, 135:825-832.
3. Saito Y. Roles of atrial natriuretic peptide and its therapeutic use. J Cardiol 2010, 56:262-270.
4. Mukoyama M., Nakao K., Hosoda K., Suga S., Saito Y., Ogawa Y. Brain natriuretic peptide (BNP) as a novel cardiac hormone in humans: evidence for an exquisite dual natriuretic peptide system, ANP and BNP. J Clin Invest 1991, 87:1402-1412.
5. Nishikimi T., Maeda N., Matsuoka H. The role of natriuretic peptides in cardioprotection. Cardiovasc Res 2006, 69:318-328.
6. Martinez-Rumayer A., Richards A.M., Burnett J.C., Januzzi J.L. Biology of the natriuretic peptides. Am J Cardiol 2008, 101:A3-A8.
7. Nishikimi T., Ikeda M., Takeda Y., Ishimitsu T., Shibasaki I., Fukuda H., Kinoshita H., Nakagawa Y., Kuwahara K., Nakao K. The effect of glycosylation on plasma N-terminal proBNP-76 levels in patients with heart or renal failure. Heart 2012, 89:152-161.
8. Sato Y., Miyamoto T., Taniguchi R., Nagao K., Matsuoka T., Fukuhara R. The clinical and hemodynamic factors that influence the concentrations of biomarkers of myocyte injury measured by high sensitive assay PATHFAST. J Cardiol 2009, 53:20-27.
9. Nakayama M., Shimasaki Y., Ito T., Nakamura S., Soejima H., Miyamoto S., Takazoe K., Ogawa H., Kugiyama K., Saito Y., Nakao K., Yasue H. Interaction on metabolic clearance between A-type and B-type natriuretic peptides in patients with heart failure. Metabolism 2000, 49:1228-1233.
10. Yamashita T., Seino Y., Ogawa A., Ogata K., Fukushima M., Tanaka K., Mizuno K. N-terminal pro-BNP is a novel biomarker for integrated cardio-renal burden and early risk stratification in patients admitted for cardiac emergency. J Cardiol 2010, 55:377-383.
11. Carr S.J., Bavanandan S., Fentum B., Ng L. Prognostic potential of brain natriuretic peptide (BNP) in predialysis chronic kidney disease patients. Clin Sci 2005, 109:75-82.
12. Kusumoto A., Miyata M., Kubozono T., Ikeda Y., Shinsato T., Kuwahata S., Fujita S., Takasaki K., Yuasa T., Hamasaki S., Tei C. Highly sensitive cardiac troponin T in heart failure: comparison with echocardiographic parameters and natriuretic peptides. J. Cardiol. 2012, 59:202-208.
13. Kaneko H., Koike A., Senoo K., Tanaka S., Suzuki S., Nagayama O., Sagara K., Otsuka T., Matsuno S., Funada R., Uejima T., Oikawa Y., Yajima J., Nagashima K., Kirigaya H., et al. Role of cardiopulmonary dysfunction and left atrial remodeling in development of acute decompensated heart failure in chronic heart failure with preserved left ventricular ejection fraction. J Cardiol 2012, 59:359-365.
14. Spanaus K.S., Kronenberg F., Ritz E., Schlapbach R., Fliser D., Hersberger M. B-type natriuretic peptide concentrations predict the progression of nondiabetic chronic kidney disease: the Mild-to-Moderate Kidney Disease Study. Clin Chem 2007, 53:1264-1272.
15. van Kimmenade R.R., Januzzi J.L., Baggish A.L., Lainchbury J.G., Bayes-Genis A., Richards M., Pinto Y.M. Amino-terminal pro-brain natriuretic peptide, renal function, and outcomes in acute heart failure. Redefining the cardiorenal interaction?. J Am Coll Cardiol 2006, 48:1621-1627.
16. Tsutamoto T., Wada A., Sakai H., Ishikawa C., Tanaka T., Hayashi M., Fujii M., Yamamoto T., Dohke T., Ohnishi M., Takashima H., Kinoshita M., Horie M. Relationship between renal function and plasma brain natriuretic peptide in patients with heart failure. J Am Coll Cardiol 2006, 47:582-586.
17. DeFilippi C., Kimmenade R.R.J., Pinto Y.M. Amino-terminal pro-B-type natriuretic peptide testing in renal disease. Am J Cardiol 2008, 101:82A-88A.
18. Masson S., Latini R., Anand I.S., Vago T., Angelici L., Barlera S. Direct comparison of B-Type Natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data. Clin Chem 2006, 52:1528-1538.
19. Tsutamoto T., Sakai H., Nishiyama K., Tanaka T., Fujii M., Yamamoto T., Horie M. Direct comparison of transcardiac increase in brain natriuretic peptide (BNP) and N-terminal proBNP and prognosis in patients with chronic heart failure. Circ J 2007, 71:1873-1878.
20. Khan I.A., Fink J., Nass C., Chen H., Christenson R., DeFilippi C.R. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients. Am J Cardiol 2006, 97:1530-1534.
21. Matsuo S., Imai E., Horio M., Yasuda Y., Tomita K., Nitta K., Yamagata K., Tomino Y., Yokoyama H., Hishida A. Collaborators developing the Japanese equation for estimated GFR. Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009, 5:982-992.
22. CKD guideline Editional Committee Evidence-based practice guideline for the treatment of CKD. Jap J Nephrol 2009, 51:905-1066.
23. Dries D.L., Ky B., Wu A.H., Rame J.E., Putt M.E., Cappola T.P. Simultaneous assessment of unprocessed ProBNP1-108 in addition to processed BNP32 improves identification of high-risk ambulatory patients with heart failure. Circ Heart Fail 2010, 3:220-227.